1-1 of 1
Keywords: proprotein convertase subtilisin/kexin type 9 (PCSK9)
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study

Piia Simonen, Ulf-Håkan Stenman, Helena Gylling
Journal: Clinical Science
Clin Sci (Lond) (2015) 129 (5): 439–446.
https://doi.org/10.1042/CS20150193
Published: 11 June 2015
...Piia Simonen; Ulf-Håkan Stenman; Helena Gylling Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates low-density lipoprotein (LDL) cholesterol (LDL-C) metabolism by targeting LDL receptors for degradation. Statins increase serum PCSK9 concentration limiting the potential of statins...
View article titled, Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study
Open the PDF for Serum proprotein convertase subtilisin/kexin type 9 concentration is not increased by plant stanol ester consumption in normo- to moderately hypercholesterolaemic non-obese subjects. The BLOOD FLOW intervention study in another window